Completed PHASE1 INTERVENTIONAL 2-arm NCT00628706

Investigating the Acute Effects of THC on Functional Brain Systems (FIX)

Sponsor: Center for Human Drug Research

Conditions Endocannabinoids Magnetic Resonance Imaging Memory Reward Tetrahydrocannabinol

Interventions Delta9-tetrahydrocannabinol (THC)

Updated 5 times since 2017 Last updated: Feb 17, 2009 Started: Apr 30, 2008 Primary completion: Sep 30, 2008 Completion: Sep 30, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00628706, this PHASE1 trial focuses on Endocannabinoids and Magnetic Resonance Imaging and remains completed. Sponsored by Center for Human Drug Research, it has been updated 5 times since 2008, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

Apr 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Center for Human Drug Research
Leiden University Medical Center
TI Pharma
UMC Utrecht

Data source: UMC Utrecht

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Utrecht, Netherlands